Kropff, M Richardson, PG Schlag, R Khuageva, Nk Dimopoulos, MA Shpilberg, O Schots, Henri Petrucci, Mt Neuwirth, R Boral, A others, Similar Benefit in Patients Aged>= 75 Years Versus< 75 Years with VMP in First-Line MM and Bortezomib in Relapsed MM, Clinical Lymphoma Myeloma and Leukemia, (9), 12--12, 2009, Cancer Information Group, LP,